Finding alternatives to antibiotics

被引:166
作者
Allen, Heather K. [1 ]
Trachsel, Julian [1 ]
Looft, Torey [1 ]
Casey, Thomas A. [1 ]
机构
[1] ARS, USDA, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, Ames, IA 50010 USA
来源
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN | 2014年 / 1323卷
关键词
antibiotic alternatives; gut microbiota; phage therapy; predatory bacteria; bacteriocins; antibiotic prudency; RESPIRATORY-TRACT INFECTIONS; BETA-LACTAM ANTIBIOTICS; BDELLOVIBRIO-BACTERIOVORUS; COMPETITIVE-EXCLUSION; FECAL MICROBIOTA; PHAGE; BACTERIOCINS; RESISTANCE; THERAPY; GUT;
D O I
10.1111/nyas.12468
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The spread of antibiotic-resistant pathogens requires new treatments. As the rate of development of new antibiotics has severely declined, alternatives to antibiotics must be considered in both animal agriculture and human medicine. Products for disease prevention are different from those for disease treatment, and examples of both are discussed here. For example, modulating the gut microbial community, either through feed additives or fecal transplantation, could be a promising way to prevent certain diseases; for disease treatment, non-antibiotic approaches include phage therapy, phage lysins, bacteriocins, and predatory bacteria. Interestingly, several of these methods augment antibiotic efficacy by improving bacterial killing and decreasing antibiotic resistance selection. Because bacteria can ultimately evolve resistance to almost any therapeutic agent, it is important to continue to use both antibiotics and their alternatives judiciously.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 95 条
[71]   Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection [J].
Rea, Mary C. ;
Alemayehu, Debebe ;
Ross, R. Paul ;
Hill, Colin .
JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 :1369-1378
[72]   Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro [J].
Ryan, Elizabeth M. ;
Alkawareek, Mahmoud Y. ;
Donnelly, Ryan F. ;
Gilmore, Brendan F. .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2012, 65 (02) :395-398
[73]  
Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]
[74]   Fundamentals of microbial community resistance and resilience [J].
Shade, Ashley ;
Peter, Hannes ;
Allison, Steven D. ;
Baho, Didier L. ;
Berga, Merce ;
Buergmann, Helmut ;
Huber, David H. ;
Langenheder, Silke ;
Lennon, Jay T. ;
Martiny, Jennifer B. H. ;
Matulich, Kristin L. ;
Schmidt, Thomas M. ;
Handelsman, Jo .
FRONTIERS IN MICROBIOLOGY, 2012, 3
[75]   Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains [J].
Shokri, Dariush ;
Zaghian, Saeideh ;
Khodabakhsh, Fatemeh ;
Fazeli, Hossein ;
Mobasherizadeh, Sina ;
Ataei, Behrooz .
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2014, 47 (05) :371-376
[76]  
SMITH HW, 1982, J GEN MICROBIOL, V128, P307
[77]   Chemical and genetic characterization of bacteriocins: antimicrobial peptides for food safety [J].
Snyder, Abigail B. ;
Worobo, Randy W. .
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2014, 94 (01) :28-44
[78]   Bdellovibrio as therapeutic agents:: a predatory renaissance? [J].
Sockett, RE ;
Lambert, C .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (08) :669-675
[79]   'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution [J].
Stecher, Baerbel ;
Maier, Lisa ;
Hardt, Wolf-Dietrich .
NATURE REVIEWS MICROBIOLOGY, 2013, 11 (04) :277-284
[80]  
Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4